Search Result "saquinavir."
Comparative Efflux of Saquinavir, Ritonavir and Lopinavir from Primary Human Cells
Journal: Drug Metabolism Letters
Volume: 4 Issue: 4 Year: 2010 Page: 241-245
Author(s): Bilge Diker, Omar Janneh, Rolf P.G. van Heeswijk, Karen F.T. Copeland
Enhancing the Delivery of Anti Retroviral Drug “Saquinavir” Across the Blood Brain Barrier Using Nanoparticles
Journal: Current HIV Research
Volume: 8 Issue: 5 Year: 2010 Page: 396-404
Author(s): Supriya D. Mahajan, Indrajit Roy, GaiXia Xu, Ken-Tye Yong, Hong Ding, Ravikumar Aalinkeel, Jessica L. Reynolds, Donald E. Sykes, Bindukumar B. Nair, Elaine Y. Lin, Paras N. Prasad, Stanley A. Schwartz
CoMFA, CoMSIA and Docking Studies of Saquinavir Based Peptidomimetic Inhibitors of HIV-1 Protease
Journal: Current Enzyme Inhibition
Volume: 12 Issue: 2 Year: 2016 Page: 161-169
Author(s): Vandana Saini, Sakshi Piplani, Amita S. Dang, Ajit Kumar
Saquinavir/Ritonavir Monotherapy as a New Nucleoside-Sparing Maintenance Strategy in Long-Term Virologically Suppressed HIVInfected Patients
Journal: Current HIV Research
Volume: 8 Issue: 6 Year: 2010 Page: 467-470
Author(s): Patricia Echeverria, Pere Domingo, Mar Gutierrez, Mateo Gracia, Monse Fuster, Jose Molto, Jordi Puig, Nuria Perez-Alvarez, Bonaventura Clotet, Eugenia Negredo
Molecular Docking, DFT Studies and ADMET Simulations for Evaluating Already Approved FDA Drugs as Inhibitors for SARS-Cov-2 RNADependent Polymerase
Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 7 Year: 2021 Page: 674-685
Author(s): Manos C. Vlasiou,Kyriakos I. Ioannou,Kyriaki S. Pafiti
The Secreted Aspartic Proteinases as a New Target in the Therapy of Candidiasis
Journal: Current Drug Targets
Volume: 3 Issue: 5 Year: 2002 Page: 351-357
Author(s): M. Bein, M. Schaller, H.C. Korting
Successful Applications of Computer Aided Drug Discovery: Moving Drugs from Concept to the Clinic
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 127-141
Author(s): Tanaji T. Talele, Santosh A. Khedkar, Alan C. Rigby
Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2007 Page: 2734-2748
Author(s): Antonio Mastrolorenzo, Stefano Rusconi, Andrea Scozzafava, Giuseppe Barbaro, Claudiu T. Supuran
Assessment of Analytical Techniques for Precise Quantification of Four Antiviral Drugs in Pharmaceutical Research and Development: A Comprehensive Review
Journal: Current Pharmaceutical Analysis
Volume: 20 Issue: 6 Year: 2024 Page: 409-424
Author(s):
Nucleoside-Free Boosted Double PI Regimen: Significant CD4+ T-Cell Recovery in Patients with Poor Immunologic Response Despite Virologic Suppression
Journal: Current HIV Research
Volume: 6 Issue: 6 Year: 2008 Page: 555-559
Author(s): Clara Lehmann, Norma Jung, Anika Hofmann, Oliver A. Cornely, Christoph Wyen, Gerd Fatkenheuer, Pia Hartmann